Applied Nutrition Future Growth
Future criteria checks 1/6
Applied Nutrition is forecast to grow revenue at 16.1% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Personal Products earnings growth | 6.6% |
| Revenue growth rate | 16.1% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 28 Oct 2024 |
Recent future growth updates
No updates
Recent updates
No updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2027 | 123 | N/A | 21 | N/A | 1 |
| 6/30/2026 | 111 | N/A | 19 | N/A | 1 |
| 6/30/2025 | 100 | N/A | 17 | N/A | 1 |
| 7/31/2023 | 61 | 14 | 7 | 8 | N/A |
| 7/31/2022 | 35 | 8 | 6 | 6 | N/A |
| 7/31/2021 | 22 | 6 | 2 | 3 | N/A |
| 7/31/2020 | 11 | 4 | 2 | 3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if APNL's forecast earnings growth is above the savings rate (1.9%).
Earnings vs Market: Insufficient data to determine if APNL's earnings are forecast to grow faster than the UK market
High Growth Earnings: Insufficient data to determine if APNL's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: APNL's revenue (16.1% per year) is forecast to grow faster than the UK market (3.6% per year).
High Growth Revenue: APNL's revenue (16.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if APNL's Return on Equity is forecast to be high in 3 years time